New hope for haemophilia a patients: immune training may restore clotting treatment
Disease control
Recruiting now
This study tests a treatment called immune tolerance induction (ITI) in 300 people with haemophilia A who have developed inhibitors—antibodies that block standard clotting factor therapy. The goal is to retrain the immune system to accept the clotting factor again, using high dos…
Sponsor: Haemophilia Centre Rhine Main • Aim: Disease control
Last updated May 01, 2026 15:57 UTC